2015 ACIP Immunization Schedules & Recommendations and MDPH Updates
|
|
- Clarence Stewart
- 6 years ago
- Views:
Transcription
1 Massachusetts Department of Public Health Division of Epidemiology and Immunization 2015 ACIP Immunization Schedules & Recommendations and MDPH Updates Susan M. Lett, MD, MPH Medical Director, Immunization Program MDPH April 3, 2015
2 AGENDA 2015 ACIP Immunization Schedules LAIV Recommendations 9vHPV Recommendations Meningococcal B Vaccines Expanded Childhood Vaccine Availability MIIS Compliance Schedule MDPH
3 2015 Immunization Schedules Available at : and MDPH
4 2015 Recommended Immunization Schedules for Persons 0-18 Years MMWR 201;64:93. Pediatrics 2015;135:396 Available at: MDPH
5 2015 Childhood and Adolescent Changes: Immunization Schedule Schedule: MMR, Flu, Catch-up: Hib, pneumococcal, DT/Td/Tdap, varicella and minimum ages Footnotes: DTaP, Flu/LAIV, meningococcal, pneumococcal Job aids: Hib, pneumococcal, DTaP/DT/Td/Tdap MDPH
6 No. of Flu Doses Young Children MMR Travel MDPH
7 MDPH
8 Min. interval DTaP4 MDPH
9 LAIV Contra & Precau 1 or 2 Doses of PCV for High Risk MDPH
10 MCV4 guidance for high risk reorganized by vaccine type. 10
11 Childhood/Adolescent Catch-Up Schedule Job Aids To improve childhood and adolescent immunization schedules, CDC and partner organizations developed job aids to use with the current catch-up schedule. Aids for three vaccine groups were created Haemophilus influenzae type b (Hib) Pneumococcal conjugate (PCV13) Diphtheria, tetanus, and acellular pertussis-containing vaccines Can be found on CDC schedules webpage and scrolling to bottom MDPH
12 PCV Job Aid - Example MDPH
13 2015 Adult Immunization Available at: Schedule MMWR 2015;64:91. Annals of Internal Medicine 2015;64: MDPH
14 2015 Adult Immunization Schedule Changes from 2014 September 2014 pneumococcal vaccine recommendation Routine administration of 13-valent pneumococcal conjugate vaccine (PCV13) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all (PCV13-naïve) adults aged 65 years or older August 2014 influenza vaccine contraindications and precautions for live attenuated influenza vaccine (LAIV) Move "influenza antiviral use within the last 48 hours" from precautions to contraindications Move asthma and chronic lung diseases; cardiovascular, renal, and hepatic diseases; and diabetes and other conditions from contraindications to precautions October 2014 approval by Food and Drug Administration to expand approved age for recombinant influenza vaccine (RIV) Adults aged 18 years or older (changed from 18 through 49 years) can receive RIV MDPH
15 PCV13 Routinely at 65 Years MDPH
16 16
17 Contraindications Updated information about LAIV Influenza antiviral use within the last 48 hours changed from precautions to contraindications Asthma and chronic lung diseases; cardiovascular, renal, and hepatic diseases; and diabetes and other conditions changed from contraindications to precautions MDPH
18 Born with Protection MATERNAL Tdap CAMPAIGN Researched-based campaign Targeting pregnant women & prenatal healthcare providers English and Spanish materials available. MDPH 2015
19 Changes in LAIV Recommendations in Those <8 Years of Age ACIP reviewed new data from the recent flu seasons at the meeting, including interim vaccine efficacy data from this season LAIV4 did not offer better protection than IIV in young age groups ACIP did not renew its preferential recommendation for LAIV in healthy children 2 through 8 years of age They continue to recommend that children 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot. ACIP will review final vaccine efficacy data in June. ACIP meeting MDPH
20 ACIP Recommendations for 9-Valent HPV Vaccine, February 2015 CDC. MMWR 2015;64:300 at: MDPH
21 9-Valent HPV Vaccine Gardasil 9 (Merck) Licensed for use in: Females 9-26 years and males 9-15 years* License application submitted to FDA in December dose schedule Includes data on females 9-26 yrs, males 9-15 yrs VLP vaccine Targets 5 additional high risk types 6, 11, 16, 18, 31, 33, 45, 52, 58 HPV VLP * ACIP has made an off-label recommendation for use in males through 26 years of age CDC. MMWR 2015;64:300 BLA Biologics License Application VLP virus like particle Package insert available at: MDPH
22 Available HPV Vaccines Bivalent (Cervarix) Quadrivalent (Gardasil) 9-valent (Gardasil 9) Manufacturer GlaxoSmithKline Merck Merck L1 VLP types 16, 18 6, 11, 16, 18 Dose of protein Producer cells 20/20 µg 20/40/40/20 µg Baculovirus infected Trichoplusia ni insect cell line Saccharomyces cerevisiae (yeast) 6, 11, 16, 18, 31, 33, 45,52, 58 30/40/60/40 µg 20 µg for others Saccharomyces cerevisiae (yeast) Adjuvant AS04: 500 µg aluminum hydroxide 50 µg 3-O-desacyl-4 - monophosphoryl lipid A AAHS: 225 µg amorphous aluminum hydroxyphosphate sulfate AAHS: 500 µg amorphous aluminum hydroxyphosphate sulfate L1 Major capsid protein ; VLP virus like particle MDPH
23 Attribution of HPV 16/18 and HPV 31/33/45/52/58, United States Data HPV-associated cancers 64% of invasive cancers attributable to HPV 16/18 65% for females and 63% for males 21,300 cases annually 10% of invasive cancers attributable to additional 5 types 14% for females and 4% for males Cervical cancer: HPV 16 or 18 account for 66% CIN2+ lesions* 50% attributable to HPV16/18 25% attributable to 5 additional types * CIN2+: cervical intraepithelial neoplasia grade 2 or worse Saraiya M., and Hariri S. presentations at Feb 2014 ACIP Meeting (% among all HPV-associated cancers) 23
24 9-valent HPV Vaccine: Currently Available and Future Data Available: Efficacy, immunogenicity, safety in females age yrs Overall 97% efficacy, similar safety profile; slightly higher injection site AEs Immunobridging adult to adolescents age 9-15 yrs >99% seroconversion; GMTs fold higher in 9-15 yr olds Co-administration with other vaccines (Menactra and Adacel) No impact on immune response or adverse events Immunogenicity and safety in males yrs, presented at October ACIP (not included in BLA) Future: Immunogenicity of 2-dose schedules* * MDPH
25 Implementation Considerations Will be a transition period. We will know more specifics about this soon. 4vHPV and 2vHPV protect against HPV types 16 and 18 which account for almost 70% of cervical and the majority of other HPV-related cancers 9vHPV include protects against and additional 10% percent of cancers Main benefit is for females Need to avoid missed opportunities and avoid vaccine waste. MDPH
26 ACIP Recommendations for HPV Vaccines ACIP did NOT express a preference for 9vHPV9 vs. 2vHPV or 4vHPV4 for females or for 9vHPV vs. 4vHPV for males. 9vHPV, 4vHPV or 2vHPV vaccines be used for the routine vaccination of females at years and for females 13 through 26 years who have not been previously vaccinated or completed the 3-dose series Either 9vHPV or 4vHPV vaccines can be used for routine vaccination of males at years and for males through 21 years* not have not previously been vaccinated or completed the 3 dose series. Either 9vHPV or 4vHPV vaccines can be used for vaccination of men who have sex with men and immunocompromised persons (including HIV infection) through 26 years* if not previously vaccinated. *off-label recommendation. CDC. MMWR 2015;64:300 MDPH
27 ACIP Recommendations for HPV Vaccines, (cont.) The 3-dose vaccination series can be started beginning at age 9 years If a provider does not know or have available the HPV product previous administered, or if in a setting transitioning to 9vHPV, any product can be used to complete the series.* If the vaccination series is interrupted, it does not need to be restarted. Need to increase HPV immunization coverage! *off-label recommendation. CDC. MMWR 2015;64:300 MDPH
28 Don t Wait: Vaccinate Providers don t realize how infrequently adolescents come for care Vast majority of HPV vaccinations occur at preventive care visits Minnesota study: 30% of years had no preventive care visits in a 4-5 year period You may not be choosing between 4vHPV and 9vHPV; but, between 4vHPV and nothing! Nordin et al. Ann. Fam. Med. Nov 2010; 8(6): MDPH
29 Future ACIP Policy Considerations HPV Vaccines The ACIP will discuss issues related to 9vHPV for persons who have completed 3 doses of 4vHPV or 2vHPV at future meeting. 2-dose vs 3-dose schedules Stay tuned. MDPH
30 9vHPV Vaccine Summary 9HPV targets 5 additional high risk types High efficacy and immunogenicity found in trials 9vHPV, 4vHPV and 2vHPV all protect against HPV types 16 and 18 which account for 66% of cervical and the majority of other HPV-related cancers Main benefit of 9vHPV is for females Could protect against an additional 15% of cervical and 25% of cervical pre-cancers in the U.S. Over all 14% of all HPV-associated cancers in females and 4% in males attributable to additional types Vaccinating every adolescent with an HPV vaccine formulation is our main goal! MDPH
31 ACIP Meets and Makes Recommendations for the Two Newly Licensed Meningococcal Serogroup B Vaccines February 26, 2015 Recommendations, not yet published in the MMWR. When they are, they will be posted on the ACIP website at: MDPH
32 CDC Presentation at ACIP Jessica MacNeil. Presentation to the Advisory Committee on Immunization Practices, October 30,2014
33 CDC Presentation at ACIP
34 Groups at Increased Risk of Meningococcal B Disease High risk medical conditions: Persistent complement component deficiencies Functional or anatomic asplenia (including sickle cell) Microbiologists Outbreaks MDPH
35 Outbreaks Meningococcal outbreaks are rare, historically causing 2-3% of US cases Five serogroup B meningococcal clusters/outbreaks occurred on college campuses during ,400 fold increased risk in students during outbreaks MDPH
36 Recent Experience with Serogroup B Disease on College Campuses Two outbreaks of serogroup B meningococcal disease on college campuses in cases at a RI with 4,5000 students Approximately 98% received 1 dose 6 cases at an OR college with 25,000 students 2 cases were epi-linked (but not close contacts) Additional sporadic cases of serogroup B meningococcal disease among college students have been reported to CDC (Adapted and updated from ACIP meeting ) MDPH
37 Meningococcal Serogroup B (MenB) Vaccines Two MenB vaccines are now licensed in the U.S. for persons 10 25* years of age: Trumenba (Pfizer) was licensed on October 29, 2014 Bexsero (Novartis) was licensed on January 23, 2015 MenB vaccines are distinct from MenACWY conjugate vaccines because they are based on immunity to proteins rather than capsular polysaccharides * ACIP has made an off-label recommendation for use in select groups >10 years. MDPH
38 FHbp: Factor H binding protein subfamily A (variant 2,3) or subfamily B (variant 1) NHBA: Neisserial heparin binding antigen NadA: Neisserial adhesin A Vaccine 30S:B87,2012 MDPH
39 Serogroup B Vaccine: MenB-FHbp (Trumenba) Trumenba Composed of two factor H binding protein (fhbp) subtypes subfamily A/V 2,3 Subfamily b/v1 3 dose series (0, 1, 6 months) Package insert: MDPH
40 Serogroup B Vaccine: MenB-4C (Bexsero) Bexsero Components: Factor H binding protein (FHbp) subfamily B/v1 Neisserial adhesion A (NadA) Neisserial heparin binding antigen (NhbA) Outer membrane vesicles (OMV) containing PorA P1.4 2 dose series (0, 1-6 months) Package insert: MDPH
41 ACIP Recommends MenB Vaccine for Persons at Increased Risk and Outbreak Control The serogroup B meningococcal ( MenB) vaccine series should be administered to persons aged 10 years* at increased risk for meningococcal disease. (Category A) This includes: Persons with persistent complement component deficiencies. 1 Persons with anatomic or functional asplenia. 2 Microbiologists routinely exposed to isolates of Neisseria meningitidis. MenB vaccine is also recommended for persons identified to be at increased risk because of a serogroup B meningococcal disease outbreak. 1 Including inherited or chronic deficiencies in C3, C5-9 properdin factor D, factor H, or taking eculizumab ( Soliris ). 2 Including sickle cell disease. Jessica MacNeil. Presentation to the Advisory Committee on Immunization Practices, February 26, 2015 * ACIP an off-label recommendation (Meeting ) MDPH
42 Interim Outbreak Recommendations for Investigational MenB Threshold for considering vaccination campaign with MenB (investigational) vaccine Population size <5,000: 2 or more case in 6 months Population size >5,000: 3 or more cases in 6 months In addition Chemoprophylaxis of close contacts Testing of isolates: molecular genotyping Determine if outbreak isolate covered by MenB vaccine(s) Comparison of isolates from outbreak Now that licensed MenB vaccines are licensed, CDC expects to be updating these guidelines later in the year. Interim guidance for Control of serogroup B meningococcal disease outbreaks in organization settings MDPH
43 ACIP MenB Vaccines Future Considerations Recommendations for MenB vaccine for use in high risk groups and outbreak control MenB expected to be published in MMWR soon. In June, the ACIP will discuss recommendations related to possible routine use in adolescents, college students or other groups; and possible permissive recommendations CDC will be issuing updated guidelines for use of MenB vaccines for outbreak control. MDPH
44 Clinicians are Key to Increase Vaccination Coverage Provide strong recommendations Do not delay vaccination Implement evidence-based strategies to improve vaccine delivery Decrease missed opportunities MDPH 2015
45 MIIS Compliance Schedule Vaccinations Across the Lifespan MDPH
46 MIIS Timeline Legislation June 2010 Regulations January 2015 Compliance Schedule March 2015 Legislation (M.G.L. Chapter 111, Section 24M) passed charging MDPH to establish an immunization registry Approved by Mass public health council and includes: Mandated System Users Registration Reporting Type of Information/Data Confidentiality Protections Duty to Inform Goal to have all mandated users registered and using the system according to the following schedule MDPH
47 Compliance Schedule 9/1/2015 Providers that do not use electronic health record systems and will enter data directly into the web interface 12/1/2015 Providers that use electronic health record technology and administer more than 1,000 doses of vaccine per year will report immunization information through electronic data exchange 6/1/2016 Providers that use electronic health record technology and administer less than 1,000 doses of vaccine per year and will report immunizations through electronic data exchange For more information or any questions: MIIS Help Desk Tel: (617) or MDPH
48 Expanded Availability of Select Vaccines for Children through 18 Years of Age For the flu season: Influenza vaccine Beginning April 1, 2015 Hepatitis A Tdap Varicella vaccines MDPH
49 Multiple Formulations of Influenza Vaccine Will be Available Formulation Size Packaging Fluzone 0.25 ml Pre-filled syringe Fluzone 0.5 ml Single-dose vial Fluzone 5.0 ml Multi-dose vial Fluarix 0.5 ml Pre-filled syringe FluMist 0.2 ml Nasal spray MDPH
50 Ordering Catch-up Doses of HepA, Tdap, and Varicella Estimate for catch up of all children through 18 years of age Take into consideration previous private purchase in your office Order a 2-month supply of catch-up doses in addition to the replacement doses you used that month Use your privately purchased doses first, and continue to seek reimbursement from insurers until private inventory is depleted For questions or consultation, please call the MDPH Vaccine Management Unit at MDPH
51 Insurance Considerations MDPH will ask insurers to continue reimbursing providers that privately purchased hepatitis A, Tdap, and varicella through September During this transition year, MDPH will ask insurers to continue reimbursing providers that privately purchased influenza vaccine through March MDPH
52 MDPH
Immunization Update 2015
Immunization Update 2015 William Atkinson, MD, MPH* California Immunization Coalition Summit Riverside, California April 26, 2015 *Representing the Immunization Action Coalition, Saint Paul, MN Advisory
More informationImmunization Update 2015
Immunization Update 2015 William Atkinson, MD, MPH Immunization Action Coalition Kentucky Immunization Conference Louisville, Kentucky October 14, 2015 Information in this presentation are valid as of
More informationImmunization Update Tamara Sheffield, MD, MPA, MPH
Immunization Update 2015 Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed by Intermountain Healthcare
More informationImmunization Guidelines for the Use of State Supplied Vaccine May 17, 2015
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationImmunization Update. William Atkinson, MD, MPH. Immunization Action Coalition
Immunization Update William Atkinson, MD, MPH Immunization Action Coalition Coordinated School Health Conference Lake Ozark, Missouri December 3, 2016 1 Disclosures William Atkinson has no financial relationships
More informationMDPH Clinical Update Adult Coalition
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences MDPH Clinical Update Adult Coalition 1-9-2018 Susan M. Lett, MD, MPH Medical Director, Immunization Program
More informationACIP Meeting Update, New Recommendations and Pending Influenza Season
ACIP Meeting Update, New Recommendations and Pending Influenza Season February 17 th 2011 www.immunizetexas.com ACIP Upcoming Agenda and New Recommendations ACIP (February 23-24 th 2011) Topics for meeting
More informationHemagglutinin Neuraminidase
Evolving Vaccine Guidance: Influenza, Meningococcal & HPV Vaccines H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Maine Chapter AAP Bar Harbor, Maine October 16, 2016
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
May 1, 2015 Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table
More informationRecommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Routine Immunizations Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 3 References... 7 Effective Date... 4/15/2018
More informationPreteen and teen vaccines: what to do with the recent recommendations
Preteen and teen vaccines: what to do with the recent recommendations MARK H. SAWYER UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO Continuing Education The Illinois Chapter, American Academy
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationImmunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationPlatforms. Adolescent Immunization Update and the 16 Year Old Platform. Advisory Committee on Immunization Practices (ACIP)
Adolescent Immunization Update and the 16 Year Old Platform William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition Advisory Committee on Immunization Practices
More informationWHAT S NEW WITH VACCINATIONS IN 2016?
WHAT S NEW WITH VACCINATIONS IN 2016? MenB and a Few Other Changes Lynn Bahta, RN, PHN Immunization Clinical Consultant Minnesota Department of Health May 2016 Disclosure No conflict of interest Will discuss
More informationImmunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationNeedle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy
Needle Facts: Immunization Update 2015 Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy Objectives Pharmacists At the conclusion of this program, the pharmacist will be able
More informationImmunization Update 2015
Immunization Update 2015 JoEllen Wolicki BSN, RN Immunization Services Division National Center for Immunization and Respiratory Diseases Tennessee Annual Spring Immunization Review April 2015 National
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More information2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS
IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE August 30, 2010 EFFECTIVE DATE August 30, 2010 MEDICAL ASSISTANCE BULLETIN NUMBER 01-10-27, 08-10-28, 09-10-29, 31-10-30, 33-10-05 SUBJECT: Updates to the Medical Assistance Program Fee Schedule
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More informationAndrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010
2010 Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010 Disclosures No financial conflict
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More informationImmunization Update Disclosures. Candice Robinson, MD, MPH Medical Officer Immunization Services Division 5/12/2017
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Immunization Update 2017 Candice Robinson, MD, MPH Medical Officer Immunization Services Division Western
More information2017 Vaccination Update
2017 Vaccination Update NATHAN BOONSTRA, MD General Pediatrician, Blank Pediatric Clinic TODAY S OBJECTIVES Review the latest recommendations for immunizations, including HPV Meningococcal vaccines Influenza
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years United States, 2014. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationImmunization Update for Health System Pharmacists Eric Crumbaugh, PharmD
Immunization Update for Health System Pharmacists 2015 Eric Crumbaugh, PharmD Financial Disclosures Eric Crumbaugh, PharmD Speaker s Bureau Merck Vaccines Pfizer Consultant Pfizer Novartis Merck Objectives
More informationWhose Calling the Shots? - A 2019 Vaccine Update. Frank Bell Swedish Pediatric Infectious Disease Jan 2019
Whose Calling the Shots? - A 2019 Vaccine Update Frank Bell Swedish Pediatric Infectious Disease Jan 2019 2019 Vaccine Update Vaccines Meningococcal serogroup B HPV Pertussis Influenza Children with uncertain
More informationAn update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016
An update on the Human Papillomavirus Vaccines Karen Smith-McCune Professor, UCSF Department of Obstetrics, Gynecology and Reproductive Sciences John Kerner Endowed Chair I have no financial conflicts
More informationTRICARE Retail Vaccination Program Vaccine List - September 2018*
Diphtheria, tetanus and pertussis Diphtheria and tetanus toxoids adsorbed acellular pertussis adsorbed DT DTaP Diphtheria and tetanus toxoids adsorbed Daptacel, Infanrix Tetanus and diphtheria toxoids
More information5/14/2015. Meagan Burns, MPH Massachusetts Adult Immunization Conference April relevant conflict. Grant Research/Support
Meagan Burns, MPH Massachusetts Adult Immunization Conference April 2015 Consultant Grant Research/Support Speaker s Bureau Major Stockholder Other Financial or Material Interest Off Label Use of Vaccines
More information7/13/2016. Immunization Update Disclosures. Objectives. No financial disclosures to report
Immunization Update 2016 Courtney A. Robertson, PharmD Clinical Assistant Professor University of Louisiana at Monroe School of Pharmacy Disclosures No financial disclosures to report Objectives Pharmacists
More informationUpdate on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017
Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April
More informationMandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health
Mandates and More Julie Morita, M.D. Deputy Chicago Department of Public Health Why are vaccines required for school entry? School Vaccine Requirements Small pox vaccine required in Massachusetts 1855
More informationImmunization Recommendations for College Students
May 2017 ACHA Guidelines Immunization Recommendations for College Students Immunizations offer safe and effective protection from vaccine-preventable diseases and outbreaks. The United States is experiencing
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table of standardized
More informationVaccines, Not Just for Babies
Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationPreventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
More informationPediatric and Adolescent Vaccines
Pediatric and Adolescent Vaccines Andrea A. Berry, M.D. Division of Infectious Diseases and Tropical Pediatrics Center for Vaccine Development & Division of Malaria Research Overview Pediatric vaccine
More informationRECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
More informationNeedle Facts: Immunization Update 2017
Needle Facts: Immunization Update 2017 Miranda Wilhelm, Pharm.D. Clinical Associate Professor Southern Illinois University Edwardsville (SIUE) School of Pharmacy Disclosure and Conflict of Interest Miranda
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More informationImmunization Update 2013 Across the Lifespan
Immunization Update 2013 Across the Lifespan Andrew Kroger M.D., M.P.H. Medical Officer, Centers for Disease Control and Prevention New York State Association of County Health Officials (NYSACHO) New York
More information07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc.
MEDICAL POLICY SUBJECT: IMMUNIZATIONS PAGE: 1 OF: 9 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including an Essential
More informationVACCINES-WHAT HAS HAPPENED IN THE LAST YEAR. Mark H. Sawyer UCSD School of Medicine Rady Children s Hospital San Diego
VACCINES-WHAT HAS HAPPENED IN THE LAST YEAR Mark H. Sawyer UCSD School of Medicine Rady Children s Hospital San Diego LOTS HAS HAPPENED AND IT CAN BE A LITTLE CONFUSING Some people can get 2 doses of HPV
More information! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted! Traditionally
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More informationObjectives 1. Become familiar with current immunization schedules for children
Sarah Matches, DO, FAAP Assistant Professor UNTHSC, Dept. of Pediatrics Objectives 1. Become familiar with current immunization schedules for children 2. Describe the international progress in reducing
More informationDisclosures. Potential conflicts. No off-label use discussion. Safety Review Committee. Data and Safety Monitoring Board
2016 Vaccine Update Clinical Reviews Rochester, Minnesota November 2 and November 16, 2016 Robert M Jacobson, MD, FAAP Medical Director, Mayo Clinic Primary Care Immunization Program Disclosures Potential
More informationImmunization Update 2016
Immunization Update 2016 Candice L. Robinson Medical Officer Immunization Services Division New Hampshire Immunization Conference Manchester, NH March 23, 2016 Disclosures Candice Robinson is a federal
More informationAdult Vaccine Products
Adult Vaccine Products Reference Guide As always, FFF goes Beyond Distribution in its commitment to lead with integrity and a patient-centered focus. We are constantly seeking innovative solutions to reinforce
More informationImmunization Update Texas Immunization Conference
Immunization Update 2017 Texas Immunization Conference Agenda NIS Child and Teen Coverage Levels Adult Program Updates TVFC Influenza Updates TVFC Program Updates 2 1 CDC National Immunization Survey Childhood
More informationHIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan
HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan DISCLOSURES No financial or other conflicts to disclose LEARNING OBJECTIVES
More informationS404- Meningococcal Vaccines: Updated Policy Statement 2014
S404- Meningococcal Vaccines: Updated Policy Statement 2014 Michael T. Brady, MD Associate Medical Director Nationwide Children s Hospital Columbus, Ohio Disclosure of Relevant Relationship Dr. Brady (or
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Outline vaccines to be covered
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationHPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION
National Center for Immunization & Respiratory Diseases HPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION Melinda Wharton, MD, MPH Director, Immunization Services Division Mississippi Primary Health
More information2017 Immunization Update for Pharmacy Professionals
2017 Immunization Update for Pharmacy Professionals North Suburban Pharmacists of Chicagoland CPE Program May 3, 2017 Lauren B. Angelo, PharmD, MBA Associate Professor Rosalind Franklin University of Medicine
More informationPreventive care guidelines for children and adults.
Preventive care guidelines for children and adults. Keeping a focus on regular preventive care can help you and your family stay healthy. Preventive care can help you avoid potentially serious health conditions
More informationImmunization Update 2017 Adult Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2017 Adult Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Highlighted Topics Influenza Vaccine Errors 2 Dose HPV Community protection Tdap in pregnancy Meningococcal Future Recs
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationVaccines for infants- What has happened in the last year?
Vaccines for infants- What has happened in the last year? MARK H. SAWYER UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO Lots has happened and it can be a little confusing Infants used to require
More informationRecommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017
Caring for Our Children: National Health and Safety Performance Standards H Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017 In February 2017, the Recommended Immunization
More informationAdult Immunization Update April 2016
Adult Immunization Update April 2016 C. Wayne Weart, Pharm D, FASHP, FAPhA, BCPS Professor of Clinical Pharmacy and Outcome Sciences South Carolina College of Pharmacy Professor of Family Medicine Medical
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
More informationBenefit Interpretation
Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents
More information2017 HPV Vaccine Update HPV 2-Dose Schedule Recs Adult Coalition Meeting January 11, 2017
2017 HPV Vaccine Update HPV 2-Dose Schedule Recs Adult Coalition Meeting January 11, 2017 Susan M. Lett, MD, MPH Medical Director, Immunization Program Division of Epidemiology and Immunization Massachusetts
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women April 2013 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) April 2013 Risk
More information10/12/2016. Disclosures. Immunization Update Disclosures
Immunization Update 2016 JoEllen Wolicki, BSN, RN Nurse Educator Immunization Services Division 2016 Professional Immunization Seminar Erie, Pennsylvania October 20, 2016 National Center for Immunization
More informationCPT 2016 Code Changes
CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer
More informationAll Kindergarteners and 4-6 year old transfer students. 4 doses DTP or DTaP 1 dose must be at or after 4 years of age. None
Parents Vaccines Required for School Entry in Michigan Whenever children are brought into group settings, there is a chance for diseases to spread. Children must follow state vaccine laws in order to attend
More informationPARTICIPANT HANDOUTS 2015 Immunization Update
PARTICIPANT HANDOUTS 2015 Immunization Update PRESENTER Donna Weaver, RN, MN, Nurse Educator, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC)
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationNational Immunization Update
National Immunization Update H. Cody Meissner, M.D. Professor of Pediatrics Tufts Medical Center Boston, MA October 18, 2018 23 rd MIAP Immunization Conference Framingham, MA Disclaimers/Disclosure I have
More informationNational Immunization Update
National Immunization Update H. Cody Meissner, M.D. Professor of Pediatrics Tufts Medical Center Boston, MA October 18, 2018 23 rd MIAP Immunization Conference Framingham, MA Disclaimers/Disclosure I have
More informationVACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS
VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS Adult Immunization Conference April 10, 2018 Steve Fleming, EdM stephen.fleming@state.ma.us Presenter Disclosure Information I, Steve Fleming, have been
More informationImmunization Update Clark Kebodeaux, Pharm.D., BCACP
Immunization Update 2015 Clark Kebodeaux, Pharm.D., BCACP Objectives Describe the Advisory Committee on Immunization Practices (ACIP) recommendations and updates for 2014/2015 that guide current immunization
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationImmunization Update 2017
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Immunization Update 2017 Donna L. Weaver, RN, MN Nurse Educator Immunization Services Division Connecticut
More information2/29/2016. Disclosures. Learning Objectives
Cody Sasek, MPAS, PA C Assistant Professor and Academic Director Physician Assistant Education University of Nebraska Medical Center Omaha, NE Disclosures It is the policy of the University of Nebraska
More informationChild Health and Disability Prevention (CHDP) Program Code Conversion
Child Health and Disability Prevention (CHDP) Program Code Conversion Health s All s are effective for dates of service on or after July 1, 2017. (Select s for laboratory-only providers with effective
More informationNote from the National Guideline Clearinghouse (NGC): The guideline recommendations are presented in the form of tables with footnotes (see below).
Brief Summary GUIDELINE TITLE Recommended immunization schedules for persons aged 0 through 18 years: United States, 2009. BIBLIOGRAPHIC SOURCE(S) American Academy of Pediatrics Committee on Infectious
More informationImmunization Update 2017 Peds Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2017 Peds Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Highlighted Topics Influenza Vaccine Errors 2 Dose HPV Community protection Tdap in pregnancy Hepatitis B Meningococcal
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5
Summary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5 Influenza Inactivated Influenza vaccine (IIV*) or ID (intradermally) * includes recombinant influenza vaccine (RIV3)
More information8/10/17 UPDATES IN ADOLESCENT AND ADULT IMMUNIZATIONS IN AMBULATORY CARE. Objectives. Background: ACIP. Membership. Focus
UPDATES IN ADOLESCENT AND ADULT IMMUNIZATIONS IN AMBULATORY CARE Laurie L. Duran, MSN, CRNP-Adult Texas Nurse Practitioners 29 th Annual Conference Sep 2017 Objectives 1. Use available resources to interpret
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More information9/12/2018. Meningococcal Disease and Meningococcal Vaccine. Neisseria meningitidis. Meningococcal Disease Pathogenesis. Aerobic gram-negative bacteria
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Meningococcal Disease and Meningococcal Vaccine Adult Track Chapter 14 Photographs and images included
More informationAgenda. Richard Moriarty, MD, FAAP, Co-Director, MCAAP Immunization Initiative. Pentacel Vaccine Shortage Update MMRV Vaccine (Proquad ) Update
Massachusetts Department of Public Health Division of Epidemiology and Immunization Agenda Introduction Richard Moriarty, MD, FAAP, Co-Director, MCAAP Immunization Initiative Pentacel Vaccine Shortage
More information10/16/2018. Be Discuss. Describe. Discuss. Discuss 2018 ADULT IMMUNIZATION SCHEDULE INFLUENZA ADULT IMMUNIZATION UPDATE TRAINING OBJECTIVES FLUMIST
ADULT IMMUNIZATION UPDATE NORTH DAKOTA ACADEMY OF FAMILY PHYSICIANS NOVEMBER 10, 2018 Be Discuss Upon completion of the adult immunization training, participants will be able to: Discuss the general adult
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Preventative Vaccines
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Preventative Vaccines Diseases/Pathogens
More information3/10/2017. Overview N.J.A.C. 8:57-6. Purpose of N.J.A.C. 8:57-6. New Jersey Higher Education Immunization Requirements
N.J.A.C. 8:57-6 New Jersey Higher Education Immunization Requirements Jenish Sudhakaran, MPH Population Assessment Coordinator Vaccine Preventable Disease Program New Jersey Department of Health NJCHA
More information